ARCH Venture Partners X Overage, L.P.'s Net Worth

$655 Million

Who is ARCH Venture Partners X Overage, L.P.?

ARCH Venture Partners X Overage, L.P. has an estimated net worth of $655 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Neumora Therapeutics, Inc., Erasca, Inc., Verve Therapeutics, Inc., Sienna Biopharmaceuticals, Inc., and Prime Medicine, Inc..

SEC CIK

ARCH Venture Partners X Overage, L.P.'s CIK is 0001768905

Past Insider Trading and Trends

2021 was ARCH Venture Partners X Overage, L.P.'s most active year for acquiring shares with 8 total transactions. ARCH Venture Partners X Overage, L.P.'s most active month to acquire stocks was the month of January. 2021 was ARCH Venture Partners X Overage, L.P.'s most active year for disposing of shares, totalling 20 transactions. ARCH Venture Partners X Overage, L.P.'s most active month to dispose stocks was the month of January. 2023 saw ARCH Venture Partners X Overage, L.P. paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2022 ARCH Venture Partners X Overage, L.P. cashed out on 35,616,279 shares for a total of $0.00, their largest year based on trade value.